Latest Close
$0.19
News
KALA
KALA BIO, Inc. News
This news view pulls recent coverage and headlines tied to KALA.
1y Change
-$39.61 (-99.52%)
Market Cap
$3,676,493.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
TMX Newsfile • Sep 29, 2026
Read articleKala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
GlobeNewswire • Sep 24, 2026
Read articleKALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
GlobeNewswire • Sep 17, 2026
Read articleKala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests
InvestorsHub • Sep 3, 2026
Read articleKala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
GlobeNewswire • Sep 3, 2026
Read articleKala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership
InvestorsHub • Sep 1, 2026
Read article